Adds analyst comment, updates shares. STAAR Surgical (STAA) fell 8.3% as it plans to terminate its sale to Alcon (ALC) after ...

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to ...

Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company (NASDAQ: STAA) announced ...

Staar Surgical shareholders appear to reject Alcon's increased $1.6B buyout offer after Broadwood Partners leads opposition ...

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to ...

STAAR Surgical said shareholders rejected its merger with Alcon, ending the $1.6 billion deal. The eye care company will ...

Alcon’s $770 million takeover of Aerie Pharmaceuticals has delivered an early win. The lead candidate in the acquired pipeline met the primary endpoint in a pair of phase 3 dry eye trials, positioning ...

STAAR Surgical is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for moderate to high myopes Acquisition of STAAR is complementary to Alcon's laser vision ...